Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
ETFs with LCI as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|3.51%||SPDR S&P Pharmaceuticals ETF (XPH)||+19.62 (18.67%)|
|2.09%||Guggenheim S&P Smallcap 600 Pure Growth ETF (RZG)||+10.98 (14.61%)|
|1.13%||Validea Market Legends ETF (VALX)||N/A (N/A)|
Company Description (as filed with the SEC)
Lannett Company, Inc. and subsidiaries (the "Company," "Lannett," "we," or "us") was incorporated in 1942 under the laws of the Commonwealth of Pennsylvania, and reincorporated in 1991 as a Delaware corporation. We develop, manufacture, market and distribute generic versions of brand pharmaceutical products. We report financial information on a quarterly and fiscal year basis with the most recent being the fiscal year ended June 30, 2014. All references herein to a "fiscal year" or "Fiscal" refer to the applicable fiscal year ended June 30. The Company has experienced net sales growth at a compounded annual growth rate in excess of 22% over the past twelve years. In that time period net sales went from $25.1 million in fiscal year 2002 to $273.8 million in fiscal year 2014. ... More ...
Where does LCI fit in the risk graph?
|Annual EPS Est:||$1.98|
|Quarterly EPS Est:||0.95|